SYN608

· Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYN608, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]